198
Views
0
CrossRef citations to date
0
Altmetric
Papers

Mutations in the spike glycoprotein of human coronavirus OC43 modulate disease in BALB/c mice from encephalitis to flaccid paralysis and demyelination

, , , , &
Pages 279-293 | Received 03 Mar 2010, Accepted 18 May 2010, Published online: 19 Jul 2010

References

  • Allan SM, Tyrrell PJ, Rothwell NJ (2005). Interleukin-1 and neuronal injury. Nat Rev Immunol 5: 629–640.
  • Arbour N, Côtè G, Lachance C, Tardieu M, Cashman NR, Talbot PJ (1999a). Acute and persistent infection of human neural cell lines by human coronavirus OC43. J Virol 73: 3338–3350.
  • Arbour N, Ekandé S, Côté G, Lachance C, Chagnon F, Tardieu M, Cashman NR, Talbot PJ (1999b). Persistent infection of human oligodendrocytic and neuroglial cell lines by human coronavirus 229E. J Virol 73: 3326–3337.
  • Arbour N, Day R, Newcombe J, Talbot PJ (2000). Neuroinvasion by human respiratory coronaviruses. J Virol 74: 8913–8921.
  • Babcock AA, Kuziel WA, Rivest S, Owens T (2003). Chemokine expression by glial cells directs leukocytes to sites of axonal injury in the CNS. J Neurosci 23: 7922–7930.
  • Bajetto A, Bonavia R, Barbero S, Schettini G (2002). Characterization of chemokines and their receptors in the central nervous system: physiopathological implications. J Neurochem 82: 1311–1329.
  • Block ML, Hong JS (2005). Microglia and inflammation-mediated neurodegeneration: multiple triggers with a common mechanism. Prog Neurobiol 76: 77–98.
  • Bonavia A, Arbour N, Yong VW, Talbot PJ (1997). Infection of primary cultures of human neural cells by human coronaviruses 229E and OC43. J Virol 71: 800–806.
  • Buchmeier MJ, Lane TE (1999). Viral-induced neurodegenerative disease. Curr Opin Microbiol 2: 398–402.
  • Butler N, Pewe L, Trandem K, Perlman S (2006). Murine encephalitis caused by HCoV-OC43, a human coronavirus with broad species specificity, is partly immune-mediated. Virology 347: 410–421.
  • Das Sarma J, Iacono K, Gard L, Marek R, Kenyon LC, Koval M, Weiss SR (2008). Demyelinating and nondemyelinating strains of mouse hepatitis virus differ in their neural cell tropism. J Virol 82: 5519–5526.
  • Das Sarma J, Kenyon LC, Hingley ST, Shindler KS (2009). Mechanisms of primary axonal damage in a viral model of multiple sclerosis. J Neurosci 29: 10272–10280.
  • Do Carmo S, Jacomy H, Talbot PJ, Rassart E (2008). Neuroprotective effect of apolipoprotein D against human coronavirus OC43-induced encephalitis in mice. J Neurosci 28: 10330–10338.
  • Edwards JA, Denis F, Talbot PJ (2000). Activation of glial cells by human coronavirus OC43 infection. J Neuroimmunol 108: 73–81.
  • Glabinski AR, Ransohoff RM (1999). Chemokines and chemokine receptors in CNS pathology. J NeuroVirol 5: 3–12.
  • Gruol DL, Nelson TE (1997). Physiological and pathological roles of interleukin-6 in the central nervous system. Mol Neurobiol 15: 307–339.
  • Iacono KT, Kazi L, Weiss SR (2006). Both spike and background genes contribute to murine coronavirus neurovirulence. J Virol 80: 6834–6843.
  • Jackson SJ, Pryce G, Diemel LT, Cuzner ML, Baker D (2005). Cannabinoid-receptor 1 null mice are susceptible to neurofilament damage and caspase 3 activation. Neuroscience 134: 261–268.
  • Jacomy H, Fragoso G, Almazan G, Mushynski WE, Talbot PJ (2006). Human coronavirus OC43 infection induces chronic encephalitis leading to disabilities in BALB/C mice. Virology 349: 335–346.
  • Jacomy H, Talbot PJ (2003). Vacuolating encephalitis in mice infected by human coronavirus OC43. Virology 315: 20–33.
  • Jeohn GH, Kong LY, Wilson B, Hudson P, Hong JS (1998). Synergistic neurotoxic effects of combined treatments with cytokines in murine primary mixed neuron/glia cultures. J Neuroimmunol 85: 1–10.
  • Kaplin AI, Deshpande DM, Scott E, Krishnan C, Carmen JS, Shats I, Martinez T, Drummond J, Dike S, Pletnikov M, Keswani SC, Moran TH, Pardo CA, Calabresi PA, Kerr DA (2005). IL-6 induces regionally selective spinal cord injury in patients with the neuroinflammatory disorder transverse myelitis. J Clin Invest 115: 2731–2741.
  • Lahrtz F, Piali L, Spanaus KS, Seebach J, Fontana A (1998). Chemokines and chemotaxis of leukocytes in infectious meningitis. J Neuroimmunol 85: 33–43.
  • Lambert F, Jacomy H, Marceau G, Talbot PJ (2008). Titration of human coronaviruses, HCoV-229E and HCoV-OC43, by an indirect immunoperoxidase assay. Methods Mol Biol 454: 93–102.
  • Lane TE, Hardison JL, Walsh KB (2006). Functional diversity of chemokines and chemokine receptors in response to viral infection of the central nervous system. Curr Top Microbiol Immunol 303: 1–27.
  • Mennicken F, Maki R, de Souza EB, Quirion R (1999). Chemokines and chemokine receptors in the CNS: a possible role in neuroinflammation and patterning. Trends Pharmacol Sci 20: 73–78.
  • Mills KH, Dunne A (2009). Immune modulation: IL-1, master mediator or initiator of inflammation. Nat Med 15: 1363–1364.
  • Myint SH (1994). Human coronavirus—a brief review. Rev Med Virol 4: 35–46.
  • Nakajima H, Kobayashi M, Pollard RB, Suzuki F (2001). Monocyte chemoattractant protein-1 enhances HSV-induced encephalomyelitis by stimulating Th2 responses. J Leukoc Biol 70: 374–380.
  • Nakayama T, Shirane J, Hieshima K, Shibano M, Watanabe M, Jin Z, Nagakubo D, Saito T, Shimomura Y, Yoshie O (2006). Novel antiviral activity of chemokines. Virology 350: 484–492.
  • Peterson PK, Hu S, Salak-Johnson J, Molitor TW, Chao CC (1997). Differential production of and migratory response to beta chemokines by human microglia and astrocytes. J Infect Dis 175: 478–481.
  • Phillips JJ, Chua M, Seo SH, Weiss SR (2001). Multiple regions of the murine coronavirus spike glycoprotein influence neurovirulence. J NeuroVirol 7: 421–431.
  • Phillips JJ, Chua MM, Lavi E, Weiss SR (1999). Pathogenesis of chimeric MHV4/MHV-A59 recombinant viruses: the murine coronavirus spike protein is a major determinant of neurovirulence. J Virol 73: 7752–7760.
  • Probert L, Akassoglou K, Kassiotis G, Pasparakis M, Alexopoulou L, Kollias G (1997). TNF-alpha transgenic and knockout models of CNS inflammation and degeneration. J Neuroimmunol 72: 137–141.
  • St-Jean JR, Desforges M, Almazan F, Jacomy H, Enjuanes L, Talbot PJ (2006a). Recovery of a neurovirulent human coronavirus OC43 from an infectious cDNA clone. J Virol 80: 3670–3674.
  • St-Jean JR, Desforges M, Talbot PJ (2006b). Genetic evolution of human coronavirus OC43 in neural cell culture. Adv Exp Med Biol 581: 499–502.
  • Talbot PJ, Jacomy H, Desforges M (2008). Pathogenesis of human coronaviruses, other than SARS. In: Nidoviruses. Perlman S, Gallagher T, Snijder EJ (eds). Washington DC: ASM Press, pp 313–324.
  • Tsunoda I, Kuang LQ, Libbey JE, Fujinami RS (2003). Axonal injury heralds virus-induced demyelination. Am J Pathol 162: 1259–1269.
  • Tsunoda I, Tanaka T, Saijoh Y, Fujinami RS (2007). Targeting inflammatory demyelinating lesions to sites of Wallerian degeneration. Am J Pathol 171:1563–1575.
  • Wang D, Ayers MM, Catmull DV, Hazelwood LJ, Bernard CC, Orian JM (2005). Astrocyte-associated axonal damage in pre-onset stages of experimental autoimmune encephalomyelitis. Glia 51: 235–240.
  • Zhang J, Shi XQ, Echeverry S, Mogil JS, De Koninck Y, Rivest S (2007). Expression of CCR2 in both resident and bone marrow-derived microglia plays a critical role in neuropathic pain. J Neurosci 27: 12396–12406.
  • Zhang J, DeKoninck Y (2006). Spatial and temporal relationship between monocyte chemoattractant protein-1 expression and spinal glial activation following peripheral nerve injury. J Neurochem 97: 772–783.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.